World Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-125
Closed -$256K 1194
2019
Q1
$256K Buy
+125
New +$220K 0.01% 926
2018
Q4
Sell
-136
Closed -$257K 1117
2018
Q3
$257K Buy
136
+11
+9% +$22.7K 0.01% 1016
2018
Q2
$254K Buy
125
+21
+20% +$47.9K 0.01% 1041
2018
Q1
$229K Sell
104
-26
-20% -$66.1K 0.01% 1142
2017
Q4
$301K Buy
130
+1
+0.8% +$2.03K 0.01% 1138
2017
Q3
$230K Buy
+129
New +$180K 0.01% 1298

Other funds holding BLUE

World Asset Management's BLUE Position: Q2 2019 in Review

World Asset Management sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 125 shares — an estimated $256K sold.

World Asset Management first reported a position in BLUE in Q3 2017 and held it in 6 quarters. The position peaked at $301K in Q4 2017. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • World Asset Management reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • World Asset Management sold 125 bluebird bio shares in Q2 2019, an estimated $256K.
  • World Asset Management first reported a position in bluebird bio in Q3 2017 and held it in 6 quarters.
  • World Asset Management's bluebird bio position peaked at $301K in Q4 2017.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on World Asset Management's 13F filing for Q2 2019, filed 23 Jul 2019.